COMPANY

PhotoniCare

HQ: Durham, NC source · photoni.care ↗ · Southeast

Location: Durham, NC · source · Oct 14, 2026

Profile checked Oct 10, 2026

Keywords: Otitis Media Acute middle ear disease Otitis Media OtoSight Middle Ear Scope PhotoniCare OtoSight Middle Ear Scope

$4.6MRaised (2 yrs)3Trials (company is sponsor)7NIH grants

Timeline

Dec 3, 2024 Raise Private equity round — Series B: $4.6M (total, as published), announced Dec 3, 2024. Source: company release on GlobeNewswire. source ↗
Jan 10, 2024 Trial start —: Otitis Treatment With OtoSight™ - Modification of Antibiotic Treatment Intervention in Children source ↗
Jan 19, 2021 Trial start —: Clinical Development of Deep Learning for the OtoSight source ↗
Apr 15, 2019 Trial start —: Clinical Evaluation of the OtoSight source ↗

Funding

Raised: $4.6M. Last 2 years.

Dec 3, 2024 Private equity round — Series B: $4.6M (total, as published), announced Dec 3, 2024. Source: company release on GlobeNewswire. source ↗

Clinical trials (lead sponsor) 3

Record	Title	Phase	Status	Start	Primary completion
NCT06285812	Otitis Treatment With OtoSight™ - Modification of Antibiotic Treatment Intervention in Children	Not listed	Active, not recruiting	Jan 10, 2024	2026-06 (estimated)
NCT04722770	Clinical Development of Deep Learning for the OtoSight	Not listed	Completed	Jan 19, 2021	Sep 2, 2022 (actual)
NCT03890107	Clinical Evaluation of the OtoSight	Not listed	Completed	Apr 15, 2019	Apr 30, 2021 (actual)

NIH awards 7

Annual award amounts. Total $6.1M.

Aug 4, 2021 NIH award 5R44DC017422-03 FY2021: $1,015,698 awarded for that fiscal year; activity R44 (SBIR); PI SHELTON, RYAN L; recipient as written: PHOTONICARE, INC., CHAMPAIGN, IL. Clinical Development and Evaluation of a Dee source ↗
Sep 1, 2020 NIH award 2R44DC017422-02 FY2020: $1,136,886 awarded for that fiscal year; activity R44 (SBIR); PI SHELTON, RYAN L; recipient as written: PHOTONICARE, INC., CHAMPAIGN, IL. Clinical Development and Evaluation of a Dee source ↗
Jul 29, 2019 NIH award 1R43DC017422-01A1 FY2019: $223,899 awarded for that fiscal year; activity R43 (SBIR); PI SHELTON, RYAN L; recipient as written: PHOTONICARE, INC., CHAMPAIGN, IL. Development and Evaluation of a Machine Lear source ↗
Apr 12, 2019 NIH award 5R44DC014599-04 FY2019: $1,088,668 awarded for that fiscal year; activity R44 (SBIR); PI SHELTON, RYAN L; recipient as written: PHOTONICARE, INC., CHAMPAIGN, IL. Clinical Evaluation of a New Middle Ear Diag source ↗
May 4, 2018 NIH award 2R44DC014599-03 FY2018: $1,126,043 awarded for that fiscal year; activity R44 (SBIR); PI SHELTON, RYAN L; recipient as written: PHOTONICARE, INC., CHAMPAIGN, IL. Clinical Evaluation of a New Middle Ear Diag source ↗
Aug 10, 2016 NIH award 5R44DC014599-02 FY2016: $739,334 awarded for that fiscal year; activity R44 (SBIR); PI SHELTON, RYAN L; recipient as written: PHOTONICARE, INC., CHAMPAIGN, IL. Quantitative Optical Assessment of Middle Ear source ↗
Aug 25, 2015 NIH award 1R44DC014599-01 FY2015: $803,507 awarded for that fiscal year; activity R44 (SBIR); PI SHELTON, RYAN L; recipient as written: PHOTONICARE, INC., CHAMPAIGN, IL. Quantitative Optical Assessment of Middle Ear source ↗